-
1
-
-
79955772062
-
Viewpoint: Paradoxical excess mortality in the PLATO trial should be independently verified
-
Serebruany VL. Viewpoint: Paradoxical excess mortality in the PLATO trial should be independently verified. Thromb Haemost 2011; 105: 752-759.
-
(2011)
Thromb Haemost
, vol.105
, pp. 752-759
-
-
Serebruany, V.L.1
-
2
-
-
70149101223
-
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
-
Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009; 361: 1045-1057.
-
(2009)
N Engl J Med
, vol.361
, pp. 1045-1057
-
-
Wallentin, L.1
Becker, R.C.2
Budaj, A.3
-
3
-
-
0035899289
-
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
-
The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
-
The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001; 345: 494-502.
-
(2001)
N Engl J Med
, vol.345
, pp. 494-502
-
-
-
4
-
-
33751221316
-
Bivalirudin for patients with acute coronary syndromes
-
Stone GW, McLaurin BT, Cox DA, et al. Bivalirudin for patients with acute coronary syndromes. N Engl J Med 2006; 355: 2203-2216.
-
(2006)
N Engl J Med
, vol.355
, pp. 2203-2216
-
-
Stone, G.W.1
McLaurin, B.T.2
Cox, D.A.3
-
5
-
-
33645861080
-
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
-
Bhatt DL, Fox KAA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006; 354: 1706-1717.
-
(2006)
N Engl J Med
, vol.354
, pp. 1706-1717
-
-
Bhatt, D.L.1
Fox, K.A.A.2
Hacke, W.3
-
6
-
-
0037145863
-
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention
-
Steinhubl SR, Berger PB, Mann JT III, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention. J Am Med Assoc 2002; 288: 2411-2420.
-
(2002)
J Am Med Assoc
, vol.288
, pp. 2411-2420
-
-
Steinhubl, S.R.1
Berger, P.B.2
Mann III, J.T.3
-
7
-
-
0023805341
-
Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2
-
ISIS-2 (second international study of infarct survival) collaborative group
-
ISIS-2 (second international study of infarct survival) collaborative group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; ii: 349-360.
-
(1988)
Lancet
, vol.2
, pp. 349-360
-
-
-
8
-
-
0034466679
-
Debate: Subgroup analyses in clinical trials: Fun to look at-but don't believe them!
-
Sleight P. Debate: Subgroup analyses in clinical trials: fun to look at-but don't believe them! Curr Control Trials Cardiovasc Med 2000; 1: 25-27.
-
(2000)
Curr Control Trials Cardiovasc Med
, vol.1
, pp. 25-27
-
-
Sleight, P.1
-
9
-
-
0025737883
-
Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials
-
Yusuf S, Wittes J, Probstfield J, et al. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. J Am Med Assoc 1991; 266: 93-98.
-
(1991)
J Am Med Assoc
, vol.266
, pp. 93-98
-
-
Yusuf, S.1
Wittes, J.2
Probstfield, J.3
-
10
-
-
0008926519
-
Inhibition of platelet glycoprotein IIb/IIIa with etifibatide in patients with acute coronary syndromes
-
The PURSUIT Trial Investigators
-
The PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with etifibatide in patients with acute coronary syndromes. N Engl J Med 1998; 339: 436-443.
-
(1998)
N Engl J Med
, vol.339
, pp. 436-443
-
-
-
11
-
-
0033981265
-
Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes
-
Akkerhuis KM, Deckers JW, Boersma E, et al. Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Eur Heart J 2000; 21: 371-381.
-
(2000)
Eur Heart J
, vol.21
, pp. 371-381
-
-
Akkerhuis, K.M.1
Deckers, J.W.2
Boersma, E.3
-
12
-
-
79955782394
-
Safety and efficacy of prasugrel compared with clopidogrel in different regions of the world
-
epub ahead of print
-
Ruff CT, Giugliano RP, Antman EM, et al. Safety and efficacy of prasugrel compared with clopidogrel in different regions of the world. Int J Cardiol 2010; epub ahead of print.
-
(2010)
Int J Cardiol
-
-
Ruff, C.T.1
Giugliano, R.P.2
Antman, E.M.3
-
13
-
-
34247869852
-
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial
-
Bhatt DL, Flather MD, Hacke W, et al. Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol 2007; 49: 1982-1988.
-
(2007)
J Am Coll Cardiol
, vol.49
, pp. 1982-1988
-
-
Bhatt, D.L.1
Flather, M.D.2
Hacke, W.3
-
14
-
-
74449085794
-
Ticagrelor in ACS: Redefining a new standard of care?
-
Stone GW. Ticagrelor in ACS: redefining a new standard of care? The Lancet 2010; 375: 263-265.
-
(2010)
The Lancet
, vol.375
, pp. 263-265
-
-
Stone, G.W.1
-
15
-
-
67651099090
-
Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: A risk model from the ACUITY trial
-
Mehran R, Pocock SJ, Stone GW, et al. Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial. Eur Heart J 2009; 30: 1457-1466.
-
(2009)
Eur Heart J
, vol.30
, pp. 1457-1466
-
-
Mehran, R.1
Pocock, S.J.2
Stone, G.W.3
|